181 related articles for article (PubMed ID: 19487622)
1. Citalopram treatment in children with autism spectrum disorders and high levels of repetitive behavior.
Volkmar FR
Arch Gen Psychiatry; 2009 Jun; 66(6):581-2. PubMed ID: 19487622
[No Abstract] [Full Text] [Related]
2. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
[TBL] [Abstract][Full Text] [Related]
3. Drug fails to subdue repetitive behavior in children with autism spectrum disorders.
Harv Ment Health Lett; 2009 Oct; 26(4):7. PubMed ID: 19904836
[No Abstract] [Full Text] [Related]
4. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
Kolevzon A; Mathewson KA; Hollander E
J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Wheeler DM; Silove N; Hazell P
Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
[TBL] [Abstract][Full Text] [Related]
6. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
Soorya L; Kiarashi J; Hollander E
Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368
[TBL] [Abstract][Full Text] [Related]
7. Use of citalopram in pervasive developmental disorders.
Namerow L; Thomas P; Bostic JQ; Prince J; Monuteaux MC
J Dev Behav Pediatr; 2003 Apr; 24(2):104-8. PubMed ID: 12692455
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
Williams K; Brignell A; Randall M; Silove N; Hazell P
Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
[TBL] [Abstract][Full Text] [Related]
9. Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.
King BH; Dukes K; Donnelly CL; Sikich L; McCracken JT; Scahill L; Hollander E; Bregman JD; Anagnostou E; Robinson F; Sullivan L; Hirtz D
JAMA Pediatr; 2013 Nov; 167(11):1045-52. PubMed ID: 24061784
[TBL] [Abstract][Full Text] [Related]
10. Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors.
Simonoff E; Mowlem F; Pearson O; Anagnostou E; Donnelly C; Hollander E; King BH; McCracken JT; Scahill L; Sikich L; Pickles A
J Child Adolesc Psychopharmacol; 2022 May; 32(4):233-241. PubMed ID: 35501967
[No Abstract] [Full Text] [Related]
11. Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders.
Scahill L; McCracken JT; Bearss K; Robinson F; Hollander E; King B; Bregman J; Sikich L; Dukes K; Sullivan L; Anagnostou E; Donnelly C; Kim YS; Ritz L; Hirtz D; Wagner A
J Autism Dev Disord; 2012 Mar; 42(3):432-40. PubMed ID: 21667200
[TBL] [Abstract][Full Text] [Related]
12. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Moore ML; Eichner SF; Jones JR
Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
[TBL] [Abstract][Full Text] [Related]
13. Targeted treatments for symptom domains in child and adolescent autism.
Hollander E; Phillips AT; Yeh CC
Lancet; 2003 Aug; 362(9385):732-4. PubMed ID: 12957098
[TBL] [Abstract][Full Text] [Related]
14. fMRI tracks reductions in repetitive behaviors in autism: two case studies.
Dichter GS; Sikich L; Mahorney S; Felder JN; Lam KS; Turner-Brown L; Bodfish J
Neurocase; 2010 Aug; 16(4):307-16. PubMed ID: 20178033
[TBL] [Abstract][Full Text] [Related]
15. Paroxetine in autism.
Posey DI; Litwiller M; Koburn A; McDougle CJ
J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):111-2. PubMed ID: 9951204
[No Abstract] [Full Text] [Related]
16. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.
McDougle CJ; Naylor ST; Cohen DJ; Volkmar FR; Heninger GR; Price LH
Arch Gen Psychiatry; 1996 Nov; 53(11):1001-8. PubMed ID: 8911223
[TBL] [Abstract][Full Text] [Related]
17. The SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.
Herscu P; Handen BL; Arnold LE; Snape MF; Bregman JD; Ginsberg L; Hendren R; Kolevzon A; Melmed R; Mintz M; Minshew N; Sikich L; Attalla A; King B; Owley T; Childress A; Chugani H; Frazier J; Cartwright C; Murphy T;
J Autism Dev Disord; 2020 Sep; 50(9):3233-3244. PubMed ID: 31267292
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.
Mouti A; Reddihough D; Marraffa C; Hazell P; Wray J; Lee K; Kohn M
Trials; 2014 Jun; 15():230. PubMed ID: 24934401
[TBL] [Abstract][Full Text] [Related]
19. Citalopram and the Curate's egg in geriatric depression.
Carroll BJ
Am J Psychiatry; 2005 Sep; 162(9):1762; author reply 1762-3. PubMed ID: 16135653
[No Abstract] [Full Text] [Related]
20. Differential response of seven subjects with autistic disorder to clomipramine and desipramine.
Gordon CT; Rapoport JL; Hamburger SD; State RC; Mannheim GB
Am J Psychiatry; 1992 Mar; 149(3):363-6. PubMed ID: 1536276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
